# DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma

> **NCT06477211** · — · COMPLETED · sponsor: **Nanjing University** · enrollment: 292 (actual)

## Conditions studied

- Lung Adenocarcinoma
- Surgery
- Prognostic Cancer Model

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06477211
- **Lead sponsor:** Nanjing University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-01
- **Primary completion:** 2024-12-20
- **Final completion:** 2025-01-20
- **Target enrollment:** 292 (ACTUAL)
- **Last updated:** 2025-06-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06477211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06477211, "DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06477211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*